1. Home
  2. BNTC vs SOR Comparison

BNTC vs SOR Comparison

Compare BNTC & SOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • SOR
  • Stock Information
  • Founded
  • BNTC 1995
  • SOR 1968
  • Country
  • BNTC United States
  • SOR United States
  • Employees
  • BNTC N/A
  • SOR N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • SOR Investment Managers
  • Sector
  • BNTC Health Care
  • SOR Finance
  • Exchange
  • BNTC Nasdaq
  • SOR Nasdaq
  • Market Cap
  • BNTC 335.5M
  • SOR 358.4M
  • IPO Year
  • BNTC N/A
  • SOR N/A
  • Fundamental
  • Price
  • BNTC $13.24
  • SOR $44.50
  • Analyst Decision
  • BNTC Strong Buy
  • SOR
  • Analyst Count
  • BNTC 5
  • SOR 0
  • Target Price
  • BNTC $26.00
  • SOR N/A
  • AVG Volume (30 Days)
  • BNTC 40.8K
  • SOR 16.2K
  • Earning Date
  • BNTC 09-25-2025
  • SOR 01-01-0001
  • Dividend Yield
  • BNTC N/A
  • SOR 7.24%
  • EPS Growth
  • BNTC N/A
  • SOR N/A
  • EPS
  • BNTC N/A
  • SOR 6.50
  • Revenue
  • BNTC N/A
  • SOR N/A
  • Revenue This Year
  • BNTC N/A
  • SOR N/A
  • Revenue Next Year
  • BNTC N/A
  • SOR N/A
  • P/E Ratio
  • BNTC N/A
  • SOR $6.41
  • Revenue Growth
  • BNTC N/A
  • SOR N/A
  • 52 Week Low
  • BNTC $8.06
  • SOR $36.41
  • 52 Week High
  • BNTC $17.15
  • SOR $42.75
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 59.72
  • SOR 63.93
  • Support Level
  • BNTC $12.57
  • SOR $43.65
  • Resistance Level
  • BNTC $13.33
  • SOR $44.86
  • Average True Range (ATR)
  • BNTC 0.60
  • SOR 0.63
  • MACD
  • BNTC 0.10
  • SOR 0.05
  • Stochastic Oscillator
  • BNTC 95.59
  • SOR 68.46

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About SOR Source Capital Inc.

Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.

Share on Social Networks: